A Prospective, Exploratory Study of Becotatug Vedotin Plus Putlimab for Neoadjuvant Therapy and Adjuvant Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT07707167 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07707167
- Sponsor
- Jiangsu Cancer Institute & Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2028-01-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.